Content
Frontiers of Medicine >> 2020, Volume 14, Issue 6 doi: 10.1007/s11684-020-0751-3
Different sites of extranodal involvement may affect the survival of patients with relapsed or refractory non-Hodgkin lymphoma after chimeric antigen receptor T cell therapy
Department of Hematology, Tongji Hospital of Tongji University, Shanghai 200065, China
Abstract
Keywords
anti-CD19 chimeric antigen receptor T cell ; soft tissue ; bone marrow ; relapsed or refractory non-Hodgkin lymphoma
Content